Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
1134 | 2832 | 47.5 | 80% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
236 | 3 | ADENOSINE//NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS//ADENOSINE RECEPTORS | 48331 |
409 | 2 | ADENOSINE//ADENOSINE RECEPTORS//ATP | 16639 |
1134 | 1 | ADENOSINE A2A RECEPTOR//ADENOSINE//A2A RECEPTOR | 2832 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ADENOSINE A2A RECEPTOR | authKW | 1143110 | 8% | 49% | 217 |
2 | ADENOSINE | authKW | 793132 | 24% | 11% | 667 |
3 | A2A RECEPTOR | authKW | 472248 | 3% | 48% | 91 |
4 | ADENOSINE A1 RECEPTOR | authKW | 390574 | 4% | 29% | 126 |
5 | A1 RECEPTOR | authKW | 352473 | 3% | 44% | 75 |
6 | ADENOSINE RECEPTORS | authKW | 332451 | 7% | 15% | 207 |
7 | CGS 21680 | authKW | 255648 | 2% | 46% | 52 |
8 | ISTRADEFYLLINE | authKW | 251290 | 1% | 90% | 26 |
9 | SCH 58261 | authKW | 220404 | 1% | 66% | 31 |
10 | A2A ANTAGONISTS | authKW | 206125 | 1% | 68% | 28 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Neurosciences | 30295 | 59% | 0% | 1684 |
2 | Pharmacology & Pharmacy | 9163 | 34% | 0% | 968 |
3 | Behavioral Sciences | 946 | 5% | 0% | 129 |
4 | Chemistry, Medicinal | 485 | 5% | 0% | 131 |
5 | Clinical Neurology | 481 | 7% | 0% | 204 |
6 | Psychiatry | 345 | 5% | 0% | 144 |
7 | Biochemistry & Molecular Biology | 166 | 11% | 0% | 317 |
8 | Physiology | 152 | 4% | 0% | 101 |
9 | Substance Abuse | 93 | 1% | 0% | 30 |
10 | Medicine, Research & Experimental | 65 | 3% | 0% | 86 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | NEUROSCI COIMBRA | 139332 | 2% | 30% | 43 |
2 | ROBERT STONE DOW NEUROBIOL S | 97273 | 1% | 48% | 19 |
3 | SECT MOL NEUROPHARMACOL | 89676 | 1% | 40% | 21 |
4 | RS DOW NEUROBIOL S | 62130 | 0% | 41% | 14 |
5 | UNIT NEUROSCI | 47355 | 1% | 22% | 20 |
6 | POSITRON MED | 36296 | 1% | 11% | 31 |
7 | CENT NERVOUS SYST S | 34496 | 0% | 80% | 4 |
8 | STRATEG PROD PORTFOLIO | 34496 | 0% | 80% | 4 |
9 | REG INVEST BIOMED | 27715 | 1% | 12% | 22 |
10 | CENT NERVOUS SYST DEV UNIT | 21561 | 0% | 100% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BRAIN RESEARCH | 11513 | 8% | 0% | 227 |
2 | JOURNAL OF NEUROCHEMISTRY | 10124 | 5% | 1% | 141 |
3 | EUROPEAN JOURNAL OF PHARMACOLOGY | 8455 | 5% | 1% | 150 |
4 | NEUROPHARMACOLOGY | 8008 | 3% | 1% | 84 |
5 | NEUROSCIENCE LETTERS | 7728 | 5% | 0% | 151 |
6 | PURINERGIC SIGNALLING | 6314 | 1% | 4% | 16 |
7 | DRUG DEVELOPMENT RESEARCH | 6085 | 1% | 1% | 41 |
8 | NEUROSCIENCE | 4119 | 3% | 0% | 93 |
9 | PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR | 3796 | 2% | 1% | 67 |
10 | PSYCHOPHARMACOLOGY | 2910 | 2% | 0% | 58 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ADENOSINE A2A RECEPTOR | 1143110 | 8% | 49% | 217 | Search ADENOSINE+A2A+RECEPTOR | Search ADENOSINE+A2A+RECEPTOR |
2 | ADENOSINE | 793132 | 24% | 11% | 667 | Search ADENOSINE | Search ADENOSINE |
3 | A2A RECEPTOR | 472248 | 3% | 48% | 91 | Search A2A+RECEPTOR | Search A2A+RECEPTOR |
4 | ADENOSINE A1 RECEPTOR | 390574 | 4% | 29% | 126 | Search ADENOSINE+A1+RECEPTOR | Search ADENOSINE+A1+RECEPTOR |
5 | A1 RECEPTOR | 352473 | 3% | 44% | 75 | Search A1+RECEPTOR | Search A1+RECEPTOR |
6 | ADENOSINE RECEPTORS | 332451 | 7% | 15% | 207 | Search ADENOSINE+RECEPTORS | Search ADENOSINE+RECEPTORS |
7 | CGS 21680 | 255648 | 2% | 46% | 52 | Search CGS+21680 | Search CGS+21680 |
8 | ISTRADEFYLLINE | 251290 | 1% | 90% | 26 | Search ISTRADEFYLLINE | Search ISTRADEFYLLINE |
9 | SCH 58261 | 220404 | 1% | 66% | 31 | Search SCH+58261 | Search SCH+58261 |
10 | A2A ANTAGONISTS | 206125 | 1% | 68% | 28 | Search A2A+ANTAGONISTS | Search A2A+ANTAGONISTS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | FREDHOLM, BB , CHEN, JF , CUNHA, RA , SVENNINGSSON, P , VAUGEOIS, JM , (2005) ADENOSINE AND BRAIN FUNCTION.INTERNATIONAL REVIEW OF NEUROBIOLOGY, VOL 63. VOL. 63. ISSUE . P. 191 -270 | 270 | 54% | 298 |
2 | CUNHA, RA , (2016) HOW DOES ADENOSINE CONTROL NEURONAL DYSFUNCTION AND NEURODEGENERATION?.JOURNAL OF NEUROCHEMISTRY. VOL. 139. ISSUE 6. P. 1019 -1055 | 286 | 43% | 1 |
3 | PAUL, S , ELSINGA, PH , ISHIWATA, K , DIERCKX, RAJO , VAN WAARDE, A , (2011) ADENOSINE A(1) RECEPTORS IN THE CENTRAL NERVOUS SYSTEM: THEIR FUNCTIONS IN HEALTH AND DISEASE, AND POSSIBLE ELUCIDATION BY PET IMAGING.CURRENT MEDICINAL CHEMISTRY. VOL. 18. ISSUE 31. P. 4820-4835 | 168 | 63% | 27 |
4 | GOMES, CV , KASTER, MP , TOME, AR , AGOSTINHO, PM , CUNHA, RA , (2011) ADENOSINE RECEPTORS AND BRAIN DISEASES: NEUROPROTECTION AND NEURODEGENERATION.BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES. VOL. 1808. ISSUE 5. P. 1380 -1399 | 186 | 44% | 104 |
5 | XU, K , BASTIA, E , SCHWARZSCHILD, M , (2005) THERAPEUTIC POTENTIAL OF ADENOSINE A(2A) RECEPTOR ANTAGONISTS IN PARKINSON'S DISEASE.PHARMACOLOGY & THERAPEUTICS. VOL. 105. ISSUE 3. P. 267-310 | 194 | 53% | 146 |
6 | PEDATA, F , DETTORI, I , COPPI, E , MELANI, A , FUSCO, I , CORRADETTI, R , PUGLIESE, AM , (2016) PURINERGIC SIGNALLING IN BRAIN ISCHEMIA.NEUROPHARMACOLOGY. VOL. 104. ISSUE . P. 105 -130 | 162 | 37% | 9 |
7 | KOVACS, Z , KEKESI, KA , JUHASZ, G , DOBOLYI, A , (2014) THE ANTIEPILEPTIC POTENTIAL OF NUCLEOSIDES.CURRENT MEDICINAL CHEMISTRY. VOL. 21. ISSUE 6. P. 788 -821 | 187 | 48% | 8 |
8 | SVENNINGSSON, P , LE MOINE, C , FISONE, G , FREDHOLM, BB , (1999) DISTRIBUTION, BIOCHEMISTRY AND FUNCTION OF STRIATAL ADENOSINE A(2A) RECEPTORS.PROGRESS IN NEUROBIOLOGY. VOL. 59. ISSUE 4. P. 355 -396 | 191 | 51% | 313 |
9 | WEI, CJ , LI, W , CHEN, JF , (2011) NORMAL AND ABNORMAL FUNCTIONS OF ADENOSINE RECEPTORS IN THE CENTRAL NERVOUS SYSTEM REVEALED BY GENETIC KNOCKOUT STUDIES.BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES. VOL. 1808. ISSUE 5. P. 1358-1379 | 152 | 54% | 44 |
10 | FILIP, M , ZANIEWSKA, M , FRANKOWSKA, M , WYDRA, K , FUXE, K , (2012) THE IMPORTANCE OF THE ADENOSINE A(2A) RECEPTOR-DOPAMINE D-2 RECEPTOR INTERACTION IN DRUG ADDICTION.CURRENT MEDICINAL CHEMISTRY. VOL. 19. ISSUE 3. P. 317 -355 | 175 | 42% | 24 |
Classes with closest relation at Level 1 |